
India’s food regulator will require scientific proof, not assurances, when the safety of a food product is questioned, as it moves to standardise how stakeholders seek food safety reviews and changes to food standards.
From Jan 1, 2026, the Food Safety and Standards Authority of India (FSSAI) will make it mandatory for all such submissions to follow a single, standardised format backed by scientific evidence, according to a report by Times of India.
What the new format will demand
Under the revised framework, submissions must detail nutritional information, how much Indians consume the product, results of toxicological studies, and evidence for safe intake limits, along with allergy risks and supporting scientific studies, Times of India reported.
The filings will be reviewed by FSSAI’s Science and Standards Division and assessed by expert panels, which will decide whether a product can be cleared, continued, restricted or subjected to tighter limits, the report added.
No automatic recheck of foods already in the market
The new rule does not trigger an automatic re-examination of all foods already on shelves. It applies only when a stakeholder approaches FSSAI seeking a scientific risk assessment, either to introduce a new product or to review an existing one, Times of India reported.
In such cases, the burden of proving safety will rest with the applicant.
Officials told Times of India the sharper focus on Indian eating habits is critical as packaged foods become more common and overseas studies may not reflect actual exposure levels in India, where portion sizes and consumption patterns differ.
“This is an important step to protect public health… Since Indian food habits, portion sizes and sensitivities are very different from those in other countries, asking for proper proof about long-term safety, how much people eat and possible allergy risks helps make food rules more practical, science-based and safer for Indian consumers,” Anjali Bhola, dietician at National Cancer Institute, Jhajjar, All India Institute of Medical Sciences, told Times of India.
What changes for companies and consumers
FSSAI has assured stakeholders that data submitted for risk assessment will be treated as confidential and used only for scientific evaluation and policy decisions, Times of India reported.
The immediate impact is procedural but significant: companies seeking a review or standard change will have to build India-specific evidence packs, which could raise compliance costs and timelines, but also reduce ambiguity in regulatory decision-making.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.